You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Deoxycholic acid - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for deoxycholic acid and what is the scope of patent protection?

Deoxycholic acid is the generic ingredient in two branded drugs marketed by Slayback Pharma Llc and Abbvie, and is included in two NDAs. There are fifteen patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Deoxycholic acid has one hundred and forty-one patent family members in thirty-seven countries.

There are thirty-three drug master file entries for deoxycholic acid. One supplier is listed for this compound.

Recent Clinical Trials for deoxycholic acid

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 1
Massachusetts General HospitalPhase 1
Juva Skin & Laser CenterPhase 4

See all deoxycholic acid clinical trials

Pharmacology for deoxycholic acid
Drug ClassCytolytic Agent
Physiological EffectDecreased Cell Membrane Integrity
Medical Subject Heading (MeSH) Categories for deoxycholic acid
Paragraph IV (Patent) Challenges for DEOXYCHOLIC ACID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
KYBELLA Injection deoxycholic acid 10 mg/mL (2 mL) 206333 1 2018-07-13

US Patents and Regulatory Information for deoxycholic acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Slayback Pharma Llc DEOXYCHOLIC ACID deoxycholic acid SOLUTION;SUBCUTANEOUS 212296-001 Apr 2, 2021 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Abbvie KYBELLA deoxycholic acid SOLUTION;SUBCUTANEOUS 206333-001 Apr 29, 2015 AP RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for deoxycholic acid

Country Patent Number Title Estimated Expiration
Hungary E061343 ⤷  Sign Up
Austria E521355 ⤷  Sign Up
European Patent Office 2550968 Utilisation d’un sel biliaire avec un agent analgésique ou anti-inflammatoire pour l'élimination non chirurgicale de graisse (Non-surgical removal of localized fat accumulation with a bile salt in conjunction with an analgesic or anti-inflammatory agent) ⤷  Sign Up
Malaysia 160040 SYNTHETIC BILE ACID COMPOSITION, METHOD AND PREPARATION ⤷  Sign Up
Poland 1758590 ⤷  Sign Up
Hungary E025909 ⤷  Sign Up
Israel 202203 תכשיר חומצת מרה מלאכותי ושיטה להכנת החומצה (Synthetic bile acid composition and method for preparation of the bile acid) ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for deoxycholic acid

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1758590 300907 Netherlands ⤷  Sign Up PRODUCT NAME: DEOXYCHOLINEZUUR NATRIUMZOUT; REGISTRATION NO/DATE: RVG120593 20170804
3692995 301229 Netherlands ⤷  Sign Up PRODUCT NAME: DEOXYCHOLAAT; NATIONAL REGISTRATION NO/DATE: RVG120593 20170804; FIRST REGISTRATION: IS IS/1/16/071/01 20160729
1758590 132017000066197 Italy ⤷  Sign Up PRODUCT NAME: SALE SODICO DI ACIDO DESOSSICOLICO(BELKYRA); AUTHORISATION NUMBER(S) AND DATE(S): 044896013, 20161219;IS/1/16/071/01, 20160729
1758590 2017C/063 Belgium ⤷  Sign Up PRODUCT NAME: SEL DE SODIUM D'ACIDE DESOXYCHOLIQUE; AUTHORISATION NUMBER AND DATE: SE/H/1547/01/DC 20170612
1758590 122018000065 Germany ⤷  Sign Up PRODUCT NAME: DEOXYCHOLSAEURE NATRIUMSALZ; NAT. REGISTRATION NO/DATE: 98586.00.00 20180104; FIRST REGISTRATION: IS IS/1/16/071/01 20160729
1758590 PA2017006 Lithuania ⤷  Sign Up PRODUCT NAME: DEZOKSICHOLIO RUGSTIES NATRIO DRUSKA; REGISTRATION NO/DATE: LT/1/16/3960/001 20160909
2380576 20C1048 France ⤷  Sign Up PRODUCT NAME: SEL DE SODIUM DE L'ACIDE DESOXYCHOLIQUE; NAT. REGISTRATION NO/DATE: NL46299 20180810; FIRST REGISTRATION: IS - IS/1/16/071/01 20160729
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.